Santen Pharmaceutical Co., Ltd.
4536.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥63,560 | ¥84,578 | ¥92,997 | ¥77,851 |
| Short-Term Investments | ¥2,524 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥62,691 | ¥67,398 | ¥72,083 | ¥69,066 |
| Inventory | ¥59,282 | ¥59,247 | ¥51,590 | ¥49,998 |
| Other Curr. Assets | ¥7,091 | ¥10,195 | ¥7,630 | ¥8,223 |
| Total Curr. Assets | ¥195,148 | ¥221,418 | ¥224,300 | ¥205,138 |
| Property Plant & Equip (Net) | ¥74,812 | ¥72,715 | ¥72,954 | ¥74,387 |
| Goodwill | ¥0 | ¥0 | ¥8,242 | ¥0 |
| Intangibles | ¥77,583 | ¥73,677 | ¥67,225 | ¥79,612 |
| Long-Term Investments | ¥20,998 | ¥19,772 | ¥16,177 | ¥20,150 |
| Tax Assets | ¥10,614 | ¥0 | ¥10,017 | ¥10,230 |
| Other NC Assets | ¥9,981 | ¥20,541 | ¥10,362 | ¥8,790 |
| Total NC Assets | ¥193,988 | ¥186,705 | ¥184,977 | ¥193,169 |
| Other Assets | ¥1 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥389,137 | ¥408,123 | ¥409,277 | ¥398,307 |
| Liabilities | – | – | – | – |
| Payables | ¥30,612 | ¥42,361 | ¥38,989 | ¥45,121 |
| Short-Term Debt | ¥0 | ¥0 | ¥3,289 | ¥0 |
| Tax Payable | ¥3,092 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥39,873 | ¥42,533 | ¥42,320 | ¥30,982 |
| Total Curr. Liab. | ¥73,577 | ¥86,431 | ¥86,837 | ¥78,529 |
| LT Debt | ¥35,625 | ¥35,200 | ¥26,483 | ¥31,580 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥744 | ¥0 |
| Deferred Tax Liab, NC | ¥2,709 | ¥2,624 | ¥2,606 | ¥556 |
| Other NC Liab. | ¥3,619 | ¥3,655 | ¥2,969 | ¥4,432 |
| Total NC Liab. | ¥41,953 | ¥41,478 | ¥37,260 | ¥36,567 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥7,472 | ¥0 |
| Total Liabilities | ¥115,530 | ¥127,909 | ¥124,097 | ¥115,096 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥8,816 | ¥8,808 | ¥8,806 | ¥8,797 |
| Retained Earnings | ¥235,744 | ¥227,682 | ¥228,291 | ¥227,374 |
| AOCI | ¥48,736 | ¥43,944 | ¥40,509 | ¥47,842 |
| Other Equity | ¥0 | ¥0 | ¥0 | -¥1 |
| Total Equity | ¥274,767 | ¥281,265 | ¥286,242 | ¥284,028 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -¥1,160 | -¥1,051 | -¥1,061 | -¥817 |
| Total Liab. & Tot. Equity | ¥389,137 | ¥408,123 | ¥409,277 | ¥398,307 |
| Net Debt | -¥27,935 | -¥49,378 | -¥63,225 | -¥46,271 |